These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 2496461

  • 21. Alternate calcitonin and etidronate disodium therapy for Paget's bone disease.
    Perry HM, Droke DM, Avioli LV.
    Arch Intern Med; 1984 May; 144(5):929-33. PubMed ID: 6424594
    [Abstract] [Full Text] [Related]

  • 22. Paget's disease of bone: experience from a centre in southern India.
    Anjali, Thomas N, Rajaratnam S, Shanthly N, Oommen R, Seshadri MS.
    J Assoc Physicians India; 2006 Jul; 54():525-9. PubMed ID: 17089899
    [Abstract] [Full Text] [Related]

  • 23. [Etidronic acid therapy in Paget's disease of bone].
    Holz G, Delling G, Ziegler R.
    Dtsch Med Wochenschr; 1983 Dec 23; 108(51-52):1954-8. PubMed ID: 6418505
    [Abstract] [Full Text] [Related]

  • 24. Effective short term treatment of Paget's disease with oral etidronate.
    Preston CJ, Yates AJ, Beneton MN, Russell RG, Gray RE, Smith R, Kanis JA.
    Br Med J (Clin Res Ed); 1986 Jan 11; 292(6513):79-80. PubMed ID: 3080099
    [Abstract] [Full Text] [Related]

  • 25. Long-term biochemical response after bisphosphonate therapy in Paget's disease of bone. Proposed intervals for monitoring treatment.
    Alvarez L, Peris P, Guañabens N, Vidal S, Quintó L, Monegal A, Pons F, Ballesta AM, Muñoz-Gómez J.
    Rheumatology (Oxford); 2004 Jul 11; 43(7):869-74. PubMed ID: 15054158
    [Abstract] [Full Text] [Related]

  • 26. [Treatment of Paget's disease with diphosphonate (disodium ethydronate)].
    Caniggia A, Gennari C, Guideri R, Vattimo A, Nardi P.
    Minerva Med; 1976 Jan 07; 67(1):1-15. PubMed ID: 814505
    [Abstract] [Full Text] [Related]

  • 27. Proceedings: Treatment of Paget's disease of bone with disodium ethane-1-hydroxy-1,1-diphosphonate.
    de Vries HR, Bijvoet OL, Froeling PG.
    J Endocrinol; 1975 Mar 07; 64(3):51P. PubMed ID: 805820
    [No Abstract] [Full Text] [Related]

  • 28. [Non-hormonal drug treatment in Paget's disease].
    Ryckewaert A, Lemaire V, Tubiana M.
    Rev Rhum Mal Osteoartic; 1975 Nov 07; 42(11):693-8. PubMed ID: 131365
    [Abstract] [Full Text] [Related]

  • 29. [Treatment of Paget's disease with phosphonates].
    Reiner M, Jung A, Seiler A, Schenk R, Fleisch H.
    Schweiz Med Wochenschr; 1975 Dec 13; 105(50):1701-3. PubMed ID: 1215960
    [Abstract] [Full Text] [Related]

  • 30. Review of fracture experience during treatment of Paget's disease of bone with etidronate disodium (EHDP).
    Johnston CC, Altman RD, Canfield RE, Finerman GA, Taulbee JD, Ebert ML.
    Clin Orthop Relat Res; 1983 Dec 13; (172):186-94. PubMed ID: 6401608
    [No Abstract] [Full Text] [Related]

  • 31. [The long-term results of ethanehydroxydiphosphonate treatment in Paget's disease of bone].
    Morales Piga A, Corres González J, Pérez Ruiz F.
    Rev Clin Esp; 1991 Oct 13; 189(5):213-7. PubMed ID: 1801068
    [Abstract] [Full Text] [Related]

  • 32. Five years of clinical experience with intermittent cyclical etidronate for postmenopausal osteoporosis.
    Storm T, Kollerup G, Thamsborg G, Genant HK, Sørensen OH.
    J Rheumatol; 1996 Sep 13; 23(9):1560-4. PubMed ID: 8877926
    [Abstract] [Full Text] [Related]

  • 33. Etidronate disodium for Paget's disease.
    Med Lett Drugs Ther; 1978 Sep 08; 20(18):78-9. PubMed ID: 99647
    [No Abstract] [Full Text] [Related]

  • 34. Hereditary hyperphosphatasia: 20 year follow-up and response to disodium etidronate.
    Singer F, Siris E, Shane E, Dempster D, Lindsay R, Parisien M.
    J Bone Miner Res; 1994 May 08; 9(5):733-8. PubMed ID: 8053403
    [Abstract] [Full Text] [Related]

  • 35. [Paget's disease: errors to be avoided].
    Fournié A, Fournié B, Lassoued S.
    Rev Prat; 1989 Apr 27; 39(13):1143-6. PubMed ID: 2499920
    [Abstract] [Full Text] [Related]

  • 36. [EHDP (ethylidene-1-hydroxy-1,1-diphosphonate) in the treatment of polyosseous Paget disease].
    Kovarik J, Niebauer B, Woloszczuk W, Frühwald F, Kolbe H.
    Wien Klin Wochenschr; 1985 Mar 29; 97(7):311-5. PubMed ID: 3922124
    [Abstract] [Full Text] [Related]

  • 37. Spontaneous fractures in a patient treated with low doses of etidronic acid (disodium etidronate).
    Eyres KS, Marshall P, McCloskey E, Douglas DL, Kanis JA.
    Drug Saf; 1992 Mar 29; 7(2):162-5. PubMed ID: 1605902
    [Abstract] [Full Text] [Related]

  • 38. Risedronate and pamidronate treatment in the clinical management of patients with severe Paget's disease of bone and acquired resistance to bisphosphonates.
    Rendina D, Mossetti G, Viceconti R, Sorrentino M, Nunziata V.
    Calcif Tissue Int; 2004 Sep 29; 75(3):189-96. PubMed ID: 15148558
    [Abstract] [Full Text] [Related]

  • 39. Successful treatment of resistant Paget's disease of bone with pamidronate.
    Mallette LE.
    Arch Intern Med; 1989 Dec 29; 149(12):2765-7. PubMed ID: 2596945
    [Abstract] [Full Text] [Related]

  • 40. Vitamin D in Paget's disease of bone.
    Foldes J, Shamir S, Kidroni G, Menczel J.
    Clin Orthop Relat Res; 1989 Jun 29; (243):275-9. PubMed ID: 2498022
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.